We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
(+41%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
38.29%
Top 10 Holdings %
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$13.6M |
| 2 |
Merck
MRK
|
+$12.5M |
| 3 |
Intuitive Surgical
ISRG
|
+$11.1M |
| 4 |
DOCU
DocuSign
DOCU
|
+$10.9M |
| 5 |
Insulet
PODD
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$7.26M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$6.86M |
| 3 |
Incyte
INCY
|
+$6.31M |
| 4 |
Fidelity National Information Services
FIS
|
+$5.73M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Healthcare | 16.13% |
| 4 | Industrials | 12.13% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Camping World
CWH
$694M
| $426K | 0.05% |
20,850
-54,904
| -72% | -$1.45M |
|
427
HubSpot
HUBS
$12.7B
| $425K | 0.05% |
+862
| New | +$450K |
|
428
Whirlpool
WHR
$2.54B
| $419K | 0.05% |
+3,136
| New | +$443K |
|
429
10x Genomics
TXG
$5.97B
| $419K | 0.05% |
+10,161
| New | +$529K |
|
430
UFP Industries
UFPI
$5.18B
| $417K | 0.05% |
4,070
+761
| +23% | +$76.9K |
|
431
Bio-Techne
TECH
$11.2B
| $415K | 0.05% |
+6,094
| New | +$481K |
|
|
FOLD
432
DELISTED
Amicus Therapeutics
FOLD
| $414K | 0.05% |
34,040
-29,538
| -46% | -$381K |
|
433
Enphase Energy
ENPH
$5.52B
| $412K | 0.05% |
+3,428
| New | +$488K |
|
|
LAC
434
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $411K | 0.05% |
+24,144
| New | +$456K |
|
435
Spire
SR
$4.73B
| $407K | 0.05% |
+7,193
| New | +$436K |
|
436
Norfolk Southern
NSC
$75.6B
| $405K | 0.05% |
+2,058
| New | +$445K |
|
437
IDEX
IEX
$17.2B
| $404K | 0.05% |
1,940
-792
| -29% | -$172K |
|
438
Itron
ITRI
$4.42B
| $401K | 0.05% |
+6,623
| New | +$455K |
|
439
HEICO Corp Class A
HEI.A
$36.6B
| $400K | 0.05% |
+3,092
| New | +$419K |
|
440
Monolithic Power Systems
MPWR
$66B
| $394K | 0.05% |
+853
| New | +$436K |
|
441
VeriSign
VRSN
$27B
| $382K | 0.04% |
1,888
+553
| +41% | +$115K |
|
442
Alight
ALIT
$517M
| $382K | 0.04% |
+2,696
| New | +$453K |
|
443
YPF
YPF
$20B
| $382K | 0.04% |
31,192
-90,155
| -74% | -$1.27M |
|
444
Domino's
DPZ
$12.1B
| $380K | 0.04% |
+1,004
| New | +$386K |
|
445
Brown & Brown
BRO
$24B
| $379K | 0.04% |
5,423
-3,828
| -41% | -$273K |
|
446
BP
BP
$109B
| $377K | 0.04% |
9,747
-5,410
| -36% | -$201K |
|
447
Entegris
ENTG
$22B
| $377K | 0.04% |
+4,013
| New | +$402K |
|
448
Lennar Class A
LEN
$20.5B
| $376K | 0.04% |
3,465
-14,509
| -81% | -$1.7M |
|
449
Northern Trust
NTRS
$33.3B
| $374K | 0.04% |
5,388
-14,871
| -73% | -$1.12M |
|
450
Aptiv
APTV
$10.1B
| $373K | 0.04% |
+3,783
| New | +$391K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.
- Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
- Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
- Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
- Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
- Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
- Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
- Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.
Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.